Cargando...
Drug resistance to targeted therapies: Déjà vu all over again
A major limitation of targeted anticancer therapies is intrinsic or acquired resistance. This review emphasizes similarities in the mechanisms of resistance to endocrine therapies in breast cancer and those seen with the new generation of targeted cancer therapeutics. Resistance to single‐agent canc...
Guardado en:
| Publicado en: | Mol Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528618/ https://ncbi.nlm.nih.gov/pubmed/24910388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.05.004 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|